Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
236,833,431
-
Number of holders
-
17
-
Total 13F shares, excl. options
-
9,228,077
-
Shares change
-
-125,403
-
Total reported value, excl. options
-
$45,033,000
-
Value change
-
-$611,446
-
Number of buys
-
6
-
Number of sells
-
-4
-
Price
-
$4.88
Significant Holders of ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) as of Q1 2017
17 filings reported holding ADMA - ADMA BIOLOGICS, INC. - COMMON STOCK as of Q1 2017.
ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) has 17 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9,228,077 shares
of 236,833,431 outstanding shares and own 3.9% of the company stock.
Largest 10 shareholders include Aisling Capital LLC (3,608,171 shares), Biomark Capital Management Co. LLC (1,433,304 shares), Consonance Capital Management LP (1,273,933 shares), Broadfin Capital, LLC (1,028,672 shares), PERCEPTIVE ADVISORS LLC (721,102 shares), FMR LLC (399,700 shares), FRANKLIN RESOURCES INC (359,499 shares), VANGUARD GROUP INC (150,028 shares), Iguana Healthcare Management, LLC (100,000 shares), and Weiss Multi-Strategy Advisers LLC (40,000 shares).
This table shows the top 17 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.